|Free Dividend Report|
|Stock Splits Calendar|
|KOOL Stock Split History|
|Preferred Stock Newsletter|
|Top Option Ideas|
|Stock Message Boards|
Cesca Therapeutics (KOOL) has 3 splits in our KOOL split history database. The first split for KOOL took place on June 17, 1996. This was a 1 for 2 reverse split, meaning for each 2 shares of KOOL owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 500 share position following the split. KOOL's second split took place on March 07, 2016. This was a 1 for 20 reverse split, meaning for each 20 shares of KOOL owned pre-split, the shareholder now owned 1 share. For example, a 500 share position pre-split, became a 25 share position following the split. KOOL's third split took place on June 05, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of KOOL owned pre-split, the shareholder now owned 1 share. For example, a 25 share position pre-split, became a 2.5 share position following the split.
When a company such as Cesca Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the KOOL split history from start to finish, an original position size of 1000 shares would have turned into 2.5 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cesca Therapeutics shares, starting with a $10,000 purchase of KOOL, presented on a split-history-adjusted basis factoring in the complete KOOL split history.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-29.52%|
|About Cesca Therapeutics|
|Cesca Therapeutics develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. Co. develops and supplies automation technologies for the isolation, purification and storage of stem cells for the cord blood banking industry. Through its ThermoGenesis Corp. subsidiary, Co. provides the AutoXpress® and BioArchive® platforms for automated clinical bio-banking, PXP® platform for point-of-care cell-based therapies and CAR-TXpress platform under development for bio-manufacturing for immuno-oncology applications. Co. is also developing autologous cell-based therapies that address needs in the vascular and orthopedic markets. According to our KOOL split history records, Cesca Therapeutics has had 3 splits.|
|KOOL Split History Table|
|06/17/1996||1 for 2|
|03/07/2016||1 for 20|
|06/05/2019||1 for 10|
|Healthcare Stock Splits|
|KOOL is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
Also explore: KOOL shares outstanding history